Filing Flows › 4D Molecular Therapeutics (FDMT) › How it makes money
How 4D Molecular Therapeutics (FDMT) makes money
4D Molecular Therapeutics (FDMT) made $3.8M of revenue in the second quarter 2026 (Q2 2026), up 252-fold from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $3.8M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $3.8M | 252× |
| Q1 2026 | $3.0M | 218× |
| Q4 2025 | $85.1M | 85,090× |
| Q3 2025 | $90K | 30× |
| Q2 2025 | $15K | +200% |
| Q1 2025 | $14K | -50% |
| Q4 2024 | $1K | — |
From 4D Molecular Therapeutics' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does 4D Molecular Therapeutics make money?
4D Molecular Therapeutics (FDMT) made $3.8M of revenue in the second quarter 2026 (Q2 2026), up 252-fold from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.